E O’Brien

4.8k citations
75 papers · 3.7k · 1 hit paper · h-index 28

Impact in

Papers in

E O’Brien

73 papers receiving 3.5k citations

E O’Brien's Hit Papers

Reduced cardiotoxicity and comparable efficacy in a phase IIItrial of pegylated liposomal doxorubicin HCl(CAELYX™/Doxil®) versus conventional doxorubicin forfirst-line treatment of metastatic breast cancer 2004 · 1.4k citations
1.4k0+7+14Years since publication4008001.2k

Peers

E O’Brien
Comparison fields: 5 of 150
  • Biomaterials 656
  • Cardiology and Cardiovascular Medicine 903
  • Oncology 632
  • Cancer Research 268
  • Pulmonary and Respiratory Medicine 552
Replace Howard Leong‐Poi with:
Howard Leong‐Poi Canada
Juying Qian China
Chi‐Hang Lee Singapore
Hung‐I Yeh Taiwan
László Rosivall Hungary
Wei‐Ming Li Taiwan
Mark L. Barr United States
Kentaro Shimokado Japan
John D. Mitchell United States
Enoch Bortey United States
E O’Brien relative to Howard Leong‐Poi Canada Howard Leong‐Poi's profile →
Citations per field
00.5×2×3.3×
Howard Leong‐Poi · 1×
Citations per year

Countries citing papers authored by E O’Brien

Since Specialization
Citations

This map shows the geographic impact of E O’Brien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E O’Brien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E O’Brien more than expected).

Fields of papers citing papers by E O’Brien

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E O’Brien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E O’Brien. The network helps show where E O’Brien may publish in the future.

Co-authors

The 25 scholars most cited alongside E O’Brien, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with E O’Brien Line = papers co-authored together E O’Brien links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 75 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Reduced cardiotoxicity and comparable efficacy in a phase IIItrial of pegylated liposomal doxorubicin HCl(CAELYX™/Doxil®) versus conventional doxorubicin forfirst-line treatment of metastatic breast cancer
Hit paper breakdown →
20041416
2 2000365
3 1992156
4 2004116
5 1993114
6 200588
7 200183
8 198282
9 200880
10
Consensus document on non-invasive ambulatory blood pressure monitoring
199076
11 199872
12 198359
13 201156
14 201455
15
Blood pressure measurement : recommendations of the British Hypertension Society
199753
16 202250
17 200647
18 201546
19
Social Media Spread During Covid-19: The Pros and Cons of Likes and Shares.
202043
20 198341

About E O’Brien

E O’Brien is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine, Oncology, Molecular Biology and Surgery, having authored 75 papers that have together received 3.7k indexed citations. Recurring topics across this work include Blood Pressure and Hypertension Studies (15 papers), Lung Cancer Treatments and Mutations (7 papers), Heart Rate Variability and Autonomic Control (6 papers), Cardiovascular Health and Disease Prevention (5 papers), Lung Cancer Diagnosis and Treatment (5 papers), Hemodynamic Monitoring and Therapy (4 papers), Lung Cancer Research Studies (4 papers) and Cancer Treatment and Pharmacology (4 papers). The work is most often cited by research in Biomaterials (656 citations), Cardiology and Cardiovascular Medicine (903 citations), Oncology (632 citations), Cancer Research (268 citations) and Pulmonary and Respiratory Medicine (552 citations). E O’Brien has collaborated with scholars based in Ireland, United Kingdom and United States. Frequent co-authors include Nely Wigler, L. Mellars, Stephen P. Ackland, Raphael Catane, D G Kieback, Armando Santoro, Eva‐Maria Grischke, R. Rosso, Leila Alland and Piotr Tomczak. Their work appears in journals such as Annals of Oncology, Lung Cancer, American Journal of Hypertension, British Journal of Cancer and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact